Related Experiment Video

Updated: Jun 2, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

Extramuscular manifestations in children with severe congenital myopathy due to ACTA1 gene mutations

Yoshiaki Saito1, Hirofumi Komaki, Ayako Hattori

  • 1Department of Child Neurology, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8551, Japan. saitoyo@ncnp.go.jp

Neuromuscular Disorders : NMD
|April 26, 2011
PubMed

Insights

Severe infantile congenital myopathy linked to ACTA1 mutations also impacts brain development, causing delays and malformations. This suggests alpha-skeletal muscle actin plays a role beyond muscles during fetal development.

Area of Science:

  • Genetics
  • Neurology
  • Developmental Biology

Background:

  • Congenital myopathies are genetic muscle disorders affecting infants.
  • ACTA1 gene mutations are a known cause of severe infantile myopathy.
  • The full spectrum of ACTA1 mutation effects is not completely understood.

Observation:

  • Three infants with severe infantile myopathy due to dominant ACTA1 mutations were studied.
  • Patients exhibited muscle weakness, developmental delay in word comprehension, frontal lobe hypoplasia, and lateral ventricular dilatation.
  • One patient presented with additional congenital malformations, including skeletal dysplasia, hepatomegaly, and urinary tract stenosis.

Findings:

  • Dominant ACTA1 mutations can lead to significant extramuscular manifestations.
  • Observed neurological and developmental issues suggest non-skeletal muscle roles for alpha-skeletal muscle actin.
  • The findings highlight a potential link between ACTA1 mutations and fetal development.

Implications:

  • Alpha-skeletal muscle actin (ACTA1) may have crucial functions in non-muscle tissues during embryonic development.
  • Understanding these extramuscular effects is vital for diagnosing and managing patients with ACTA1-related disorders.
  • Further research into ACTA1's role in fetal development could reveal new therapeutic targets.

More Related Videos

Aip1p Dynamics Are Altered by the R256H Mutation in Actin08:57

Aip1p Dynamics Are Altered by the R256H Mutation in Actin

Published on: July 30, 2014

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Actin Polymerization and Cell Motility01:13

Actin Polymerization and Cell Motility

Actin is a family of globular proteins that are highly abundant in eukaryotic cells. It makes up approximately 1-5% of total cell protein concentration. Actin monomers polymerize to form a complex network of polarized filaments, the actin cytoskeleton, that plays a crucial role in many cellular processes, including cell motility, division, endocytosis, and metastasis of cancer cells.
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.